LifeVantage Corp. Announces Director Changes and Executive Compensation Details
Ticker: LFVN · Form: 8-K · Filed: Dec 9, 2025 · CIK: 849146
| Field | Detail |
|---|---|
| Company | Lifevantage Corp (LFVN) |
| Form Type | 8-K |
| Filed Date | Dec 9, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, executive-compensation, board-of-directors
Related Tickers: LFVN
TL;DR
Board shakeup at LifeVantage: Director out, new one in. Exec comp details also filed.
AI Summary
LifeVantage Corp. announced on December 3, 2025, the departure of Director W. Kirk Beecroft and the appointment of new Director Dr. Robert Sinnott. The company also reported on compensatory arrangements for its named executive officers, though specific details of these arrangements were not provided in this filing.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and changes in executive compensation can sometimes indicate underlying issues or strategic shifts within a company.
Key Players & Entities
- LifeVantage Corp. (company) — Registrant
- W. Kirk Beecroft (person) — Departing Director
- Dr. Robert Sinnott (person) — Appointed Director
- December 3, 2025 (date) — Date of earliest event reported
- December 8, 2025 (date) — Date as of change
- December 9, 2025 (date) — Filing date
FAQ
Who has departed from the Board of Directors of LifeVantage Corp.?
W. Kirk Beecroft has departed from the Board of Directors of LifeVantage Corp.
Who has been appointed as a new Director to LifeVantage Corp.'s Board?
Dr. Robert Sinnott has been appointed as a new Director to LifeVantage Corp.'s Board.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported is December 3, 2025.
What is the filing date of this 8-K report?
The filing date of this 8-K report is December 9, 2025.
What specific item information is being reported in this 8-K filing?
The filing reports on the Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; and Compensatory Arrangements of Certain Officers.
Filing Stats: 407 words · 2 min read · ~1 pages · Grade level 14 · Accepted 2025-12-08 21:13:55
Key Financial Figures
- $0.0001 — ) of the Act: Common Stock, par value $0.0001 LFVN The Nasdaq Stock Market LLC Title
Filing Documents
- lfvn-20251203.htm (8-K) — 23KB
- 0001628280-25-055939.txt ( ) — 138KB
- lfvn-20251203.xsd (EX-101.SCH) — 2KB
- lfvn-20251203_lab.xml (EX-101.LAB) — 22KB
- lfvn-20251203_pre.xml (EX-101.PRE) — 13KB
- lfvn-20251203_htm.xml (XML) — 3KB
From the Filing
lfvn-20251203 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 8-K ______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2025 ______________________________ LIFEVANTAGE CORP ORATION (Exact name of registrant as specified in its charter) ______________________________ Delaware 001-35647 90-0224471 (State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.) 3300 Triumph Blvd , Suite 700 Lehi , Utah 84043 (Address of principal executive offices, including zip code) ( 801 ) 432-9000 (Registrant's telephone number) _____________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Common Stock, par value $0.0001 LFVN The Nasdaq Stock Market LLC Title of each class Trading Symbol(s) Name of each exchange on which registered Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 3, 2025, Julie Boyster, the Chief Marketing Officer of LifeVantage Corporation (the "Company"), notified the Company of her intention to resign from such role, effective December 12, 2025, to pursue other business opportunities. Also on December 3, 2025, Todd Thompson, the Chief Information and Innovation Officer of the Company, notified the Company of his intention to resign from such role, effective December 24, 2025, to pursue other business opportunities. SIGNATURE Date: December 8, 2025 LIFEVANTAGE CORPORATION By: /s/ Steven R. Fife Name: Steven R. Fife Title: President and Chief Executive Officer